Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Katie Roll"'
Autor:
Mayumi Endo, Jennifer A. Sipos, Matthew D. Ringel, Kyle Porter, Haikady N. Nagaraja, John E. Phay, Lawrence A. Shirley, Clarine Long, Chadwick L. Wright, Katie Roll, Fadi A. Nabhan
Publikováno v:
Cancer Medicine, Vol 10, Iss 3, Pp 1084-1090 (2021)
Abstract Background 18 F‐Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) positive (PET+) cytologically indeterminate thyroid nodules (ITNs) have variable cancer risk in the literature. The benign call rate (BCR) o
Externí odkaz:
https://doaj.org/article/494680436bc04eb78d57252000a7e31f
Autor:
Fadi Nabhan, Elizabeth Kander, Rulong Shen, Amit Agrawal, Vineeth Sukrithan, Ye Zhou, Ashima Goyal, Katie Roll, Manisha Shah, Bhavana Konda
Publikováno v:
Case Reports in Endocrinology, Vol 2021 (2021)
Immune check point inhibitor (ICI) therapy can be a potentially effective salvage treatment for anaplastic thyroid cancer (ATC) with progression despite standard of care therapies. We report a case of unresectable treatment-naïve ATC showing a drama
Externí odkaz:
https://doaj.org/article/0ae0796ad92a48fba4823c268111c566
Autor:
Amit Agrawal, Manisha H. Shah, Ashima Goyal, Fadi Nabhan, Bhavana Konda, Katie Roll, Vineeth Sukrithan, Rulong Shen, Ye Zhou, Elizabeth Kander
Publikováno v:
Case Reports in Endocrinology, Vol 2021 (2021)
Case Reports in Endocrinology
Case Reports in Endocrinology
Immune check point inhibitor (ICI) therapy can be a potentially effective salvage treatment for anaplastic thyroid cancer (ATC) with progression despite standard of care therapies. We report a case of unresectable treatment-naïve ATC showing a drama
Autor:
Lawrence A. Shirley, Clarine Long, Chadwick Wright, Mayumi Endo, Katie Roll, Haikady N. Nagaraja, Fadi Nabhan, Jennifer A. Sipos, Kyle Porter, John E. Phay, Matthew D. Ringel
Publikováno v:
Cancer Medicine, Vol 10, Iss 3, Pp 1084-1090 (2021)
Cancer Medicine
Cancer Medicine
Background 18 F‐Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) positive (PET+) cytologically indeterminate thyroid nodules (ITNs) have variable cancer risk in the literature. The benign call rate (BCR) of Afirma
Autor:
Katie Roll, Mayumi Endo, Raheela Khawaja, Dena Tonkovich, Kyle Porter, Matthew D. Ringel, Jeanette Perlick, Fadi Nabhan, Irina Azaryan, Laura E. Ryan, Lawrence A. Shirley, Shumei Meng, John E. Phay, Jennifer A. Sipos
Publikováno v:
Thyroid
Background: The Afirma Gene Expression Classifier (GEC) has been used to further characterize cytologically indeterminate (cyto-I) thyroid nodules into either benign or suspicious categories. However, its relatively low positive predictive value (PPV
Publikováno v:
Journal of the Endocrine Society
Introduction: Somatic mutations of RAS- and BRAFV600E- are the most common driver mutation in thyroid cancer (TC) and in the majority of cases, these are mutually exclusive1,2. Clinical characteristics of TC with either RAS or BRAFV600E mutation is n